2024-11-26 01:31:54
Abbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib(ABSK021)
Corporate/ 2023-07-24
Abbisko Therapeutics announces that US F...

SHANGHAI,Jan. 30,2023-- Abbisko Therapeutics Co.,Ltd. ("Abbisko Therapeutics" hereafter) today announced that its CSF-1R inhibitor...

Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases
Health/ 2023-07-22
Alpha Biopharma Submits New Drug Applica...

SHANGHAI,Jan. 30,2023-- Alpha Biopharma,a developer of innovative drugs,announces that the Center for Drug Evaluation (CDE) of the National ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release